

Cover Story
FreeHealth Equity
By Matthew Bin Han Ong
A recent analysis of the National Cancer Institute’s workforce and grant recipients shows that Black and Hispanic scientists are dramatically underrepresented across key metrics, both intramural and extramural.
In Brief
Clinical Roundup
Drugs & Targets


NCI Trials


NCI Trials for July 2021
The National Cancer Institute approved the following clinical research studies last month. For further information, contact the principal investigator listed.
Trending Stories
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
- CBER Director Vinay Prasad dared to “say no to drugs”
- Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members















